Structures of α-synuclein filaments from multiple system atrophy.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
05
02
2020
accepted:
22
04
2020
pubmed:
29
5
2020
medline:
22
10
2020
entrez:
29
5
2020
Statut:
ppublish
Résumé
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human neurodegenerative diseases
Identifiants
pubmed: 32461689
doi: 10.1038/s41586-020-2317-6
pii: 10.1038/s41586-020-2317-6
pmc: PMC7116528
mid: EMS107716
doi:
Substances chimiques
alpha-Synuclein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
464-469Subventions
Organisme : NIA NIH HHS
ID : P30 AG010133
Pays : United States
Organisme : Medical Research Council
ID : MC_EX_MR/N027892/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A025_1013
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U01 NS110437
Pays : United States
Organisme : Medical Research Council
ID : MC_U105184291
Pays : United Kingdom
Références
Goedert, M., Jakes, R. & Spillantini, M. G. The synucleinopathies: twenty years on. J. Parkinsons Dis. 7, S51–S69 (2017).
pubmed: 28282814
pmcid: 5345650
doi: 10.3233/JPD-179005
Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).
pubmed: 9278044
Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997).
pubmed: 9197268
Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature 547, 185–190 (2017).
pubmed: 28678775
pmcid: 5552202
doi: 10.1038/nature23002
Falcon, B. et al. Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature 561, 137–140 (2018).
pubmed: 30158706
pmcid: 6204212
doi: 10.1038/s41586-018-0454-y
Falcon, B. et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold. Acta Neuropathol. 136, 699–708 (2018).
pubmed: 30276465
pmcid: 6208733
doi: 10.1007/s00401-018-1914-z
Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420–423 (2019).
pubmed: 30894745
pmcid: 6472968
doi: 10.1038/s41586-019-1026-5
Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases. eLife 8, e43584 (2019).
pubmed: 30720432
pmcid: 6375701
doi: 10.7554/eLife.43584
Zhang, W. et al. Novel tau filament fold in corticobasal degeneration. Nature 580, 283–287 (2020).
pubmed: 32050258
pmcid: 7148158
doi: 10.1038/s41586-020-2043-0
Singleton, A. B. et al. α-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841 (2003).
pubmed: 14593171
doi: 10.1126/science.1090278
Kiely, A. P. et al. α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? Acta Neuropathol. 125, 753–769 (2013).
pubmed: 23404372
pmcid: 3681325
doi: 10.1007/s00401-013-1096-7
Kiely, A. P. et al. Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Mol. Neurodegener. 10, 41 (2015).
pubmed: 26306801
pmcid: 4549856
doi: 10.1186/s13024-015-0038-3
Pasanen, P. et al. Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol. Aging 35, 2180.e1–2180. e5 (2014).
doi: 10.1016/j.neurobiolaging.2014.03.024
Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet. 46, 989–993 (2014).
pubmed: 25064009
pmcid: 4146673
doi: 10.1038/ng.3043
Dejerine, J. & Thomas, A. L’atrophie olivo-ponto-cérébelleuse. Nouv. Iconogr. Salpêtrière 13, 330–370 (1900).
Graham, J. G. & Oppenheimer, D. R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 32, 28–34 (1969).
pubmed: 5774131
pmcid: 493381
doi: 10.1136/jnnp.32.1.28
Quinn, N. Multiple system atrophy – the nature of the beast. J. Neurol. Neurosurg. Psychiatry 52 (suppl.), 78–89 (1989).
pmcid: 1033311
doi: 10.1136/jnnp.52.Suppl.78
Papp, M. I., Kahn, J. E. & Lantos, P. L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy–Drager syndrome). J. Neurol. Sci. 94, 79–100 (1989).
pubmed: 2559165
doi: 10.1016/0022-510X(89)90219-0
Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. α-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249, 180–182 (1998).
pubmed: 9682846
doi: 10.1016/S0304-3940(98)00407-8
Spillantini, M. G. et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci. Lett. 251, 205–208 (1998).
pubmed: 9726379
doi: 10.1016/S0304-3940(98)00504-7
Tu, P. H. et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 44, 415–422 (1998).
pubmed: 9749615
doi: 10.1002/ana.410440324
Kato, S. & Nakamura, H. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. Acta Neuropathol. 79, 584–594 (1990).
pubmed: 2163181
doi: 10.1007/BF00294235
Petrovic, I. N. et al. Multiple system atrophy–parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov. Disord. 27, 1186–1190 (2012).
pubmed: 22806758
doi: 10.1002/mds.25115
Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443–9449 (1998).
pubmed: 9545270
doi: 10.1074/jbc.273.16.9443
Uéda, K. et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 11282–11286 (1993).
pubmed: 8248242
doi: 10.1073/pnas.90.23.11282
pmcid: 47966
Li, H. T., Du, H. N., Tang, L., Hu, J. & Hu, H. Y. Structural transformation and aggregation of human α-synuclein in trifluoroethanol: non-amyloid component sequence is essential and β-sheet formation is prerequisite to aggregation. Biopolymers 64, 221–226 (2002).
pubmed: 12115139
doi: 10.1002/bip.10179
Crowther, R. A., Jakes, R., Spillantini, M. G. & Goedert, M. Synthetic filaments assembled from C-terminally truncated α-synuclein. FEBS Lett. 436, 309–312 (1998).
pubmed: 9801138
doi: 10.1016/S0014-5793(98)01146-6
Conway, K. A., Harper, J. D. & Lansbury, P. T. Jr. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson’s disease are typical amyloid. Biochemistry 39, 2552–2563 (2000).
pubmed: 10704204
doi: 10.1021/bi991447r
Serpell, L. C., Berriman, J., Jakes, R., Goedert, M. & Crowther, R. A. Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proc. Natl Acad. Sci. USA 97, 4897–4902 (2000).
pubmed: 10781096
doi: 10.1073/pnas.97.9.4897
pmcid: 18329
Miake, H., Mizusawa, H., Iwatsubo, T. & Hasegawa, M. Biochemical characterization of the core structure of α-synuclein filaments. J. Biol. Chem. 277, 19213–19219 (2002).
pubmed: 11893734
doi: 10.1074/jbc.M110551200
Mougenot, A. L. et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33, 2225–2228 (2012).
pubmed: 21813214
doi: 10.1016/j.neurobiolaging.2011.06.022
Luk, K. C. et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949–953 (2012).
pubmed: 23161999
pmcid: 3552321
doi: 10.1126/science.1227157
Masuda-Suzukake, M. et al. Prion-like spreading of pathological α-synuclein in brain. Brain 136, 1128–1138 (2013).
pubmed: 23466394
pmcid: 3613715
doi: 10.1093/brain/awt037
Osterberg, V. R. et al. Progressive aggregation of α-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep. 10, 1252–1260 (2015).
pubmed: 25732816
pmcid: 4351119
doi: 10.1016/j.celrep.2015.01.060
Peelaerts, W. et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340–344 (2015).
pubmed: 26061766
doi: 10.1038/nature14547
Peng, C. et al. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies. Nature 557, 558–563 (2018).
pubmed: 29743672
pmcid: 5970994
doi: 10.1038/s41586-018-0104-4
Prusiner, S. B. et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl Acad. Sci. USA 112, E5308–E5317 (2015).
pubmed: 26324905
doi: 10.1073/pnas.1514475112
pmcid: 4586853
Tarutani, A., Arai, T., Murayama, S., Hisanaga, S. I. & Hasegawa, M. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods. Acta Neuropathol. Commun. 6, 29 (2018).
pubmed: 29669601
pmcid: 5907316
doi: 10.1186/s40478-018-0532-2
Yamasaki, T. R. et al. Parkinson’s disease and multiple system atrophy have distinct α-synuclein seed characteristics. J. Biol. Chem. 294, 1045–1058 (2019).
pubmed: 30478174
doi: 10.1074/jbc.RA118.004471
Lavenir, I. et al. Silver staining (Campbell–Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson’s disease brain extracts in transgenic mice. Acta Neuropathol. Commun. 7, 148 (2019).
pubmed: 31522685
pmcid: 6745790
doi: 10.1186/s40478-019-0804-5
Klingstedt, T. et al. Luminescent conjugated oligothiophenes distinguish between α-synuclein assemblies of Parkinson’s disease and multiple system atrophy. Acta Neuropathol. Commun. 7, 193 (2019).
pubmed: 31796099
pmcid: 6892142
doi: 10.1186/s40478-019-0840-1
Strohäker, T. et al. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts. Nat. Commun. 10, 5535 (2019).
pubmed: 31797870
pmcid: 6893031
doi: 10.1038/s41467-019-13564-w
Shahnawaz, M. et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy. Nature 578, 273–277 (2020).
pubmed: 32025029
pmcid: 7066875
doi: 10.1038/s41586-020-1984-7
Campbell, B. C. V. et al. The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson’s disease. J. Neurochem. 76, 87–96 (2001).
pubmed: 11145981
doi: 10.1046/j.1471-4159.2001.00021.x
Fujiwara, H. et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160–164 (2002).
pubmed: 11813001
doi: 10.1038/ncb748
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469–6473 (1998).
pubmed: 9600990
doi: 10.1073/pnas.95.11.6469
pmcid: 27806
Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Nat. Struct. Mol. Biol. 23, 409–415 (2016).
pubmed: 27018801
pmcid: 5034296
doi: 10.1038/nsmb.3194
Guerrero-Ferreira, R. et al. Cryo-EM structure of alpha-synuclein fibrils. eLife 7, e36402 (2018).
pubmed: 29969391
pmcid: 6092118
doi: 10.7554/eLife.36402
Li, Y. et al. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy. Cell Res. 28, 897–903 (2018).
pubmed: 30065316
pmcid: 6123497
doi: 10.1038/s41422-018-0075-x
Li, B. et al. Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel. Nat. Commun. 9, 3609 (2018).
pubmed: 30190461
pmcid: 6127345
doi: 10.1038/s41467-018-05971-2
Guerrero-Ferreira, R. et al. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. eLife 8, e48907 (2019).
pubmed: 31815671
pmcid: 6957273
doi: 10.7554/eLife.48907
Boyer, D. R. et al. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs. Nat. Struct. Mol. Biol. 26, 1044–1052 (2019).
pubmed: 31695184
pmcid: 6907165
doi: 10.1038/s41594-019-0322-y
Boyer, D. R. et al. The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure. Proc. Natl Acad. Sci. USA 117, 3592–3602 (2020).
pubmed: 32015135
doi: 10.1073/pnas.1917914117
pmcid: 7035510
Zhao, K. et al. Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a novel fibril structure. Preprint at https://www.biorxiv.org/content/10.1101/870758v2 .
Sangwan, S. et al. Inhibition of synucleinopathic seeding by rationally designed inhibitors. eLife 9, e46775 (2020).
pubmed: 31895037
pmcid: 6977966
doi: 10.7554/eLife.46775
Goedert, M., Falcon, B., Zhang, W., Ghetti, B. & Scheres, S. H. W. Distinct conformers of assembled tau in Alzheimer’s and Pick’s diseases. Cold Spring Harb. Symp. Quant. Biol. 83, 163–171 (2018).
pubmed: 30886056
doi: 10.1101/sqb.2018.83.037580
Goedert, M., Spillantini, M. G., Cairns, N. J. & Crowther, R. A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159–168 (1992).
pubmed: 1530909
doi: 10.1016/0896-6273(92)90117-V
Giasson, B. I. et al. A panel of epitope-specific antibodies detects protein domains distributed throughout human α-synuclein in Lewy bodies of Parkinson’s disease. J. Neurosci. Res. 59, 528–533 (2000).
pubmed: 10679792
doi: 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0
Spina, S. et al. The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain 131, 72–89 (2008).
pubmed: 18065436
doi: 10.1093/brain/awm280
Nonaka, T., Watanabe, S. T., Iwatsubo, T. & Hasegawa, M. Seeded aggregation and toxicity of α-synuclein and tau: cellular models of neurodegenerative diseases. J. Biol. Chem. 285, 34885–34898 (2010).
pubmed: 20805224
pmcid: 2966103
doi: 10.1074/jbc.M110.148460
Tarutani, A. et al. The effect of fragmented pathogenic α-synuclein seeds on prion-like propagation. J. Biol. Chem. 291, 18675–18688 (2016).
pubmed: 27382062
pmcid: 5009244
doi: 10.1074/jbc.M116.734707
Kametani, F. et al. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci. Rep. 6, 23281 (2016).
pubmed: 26980269
pmcid: 4793195
doi: 10.1038/srep23281
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).
pubmed: 30412051
pmcid: 6250425
doi: 10.7554/eLife.42166
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
pubmed: 26278980
pmcid: 6760662
doi: 10.1016/j.jsb.2015.08.008
He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163–176 (2017).
pubmed: 28193500
pmcid: 5479445
doi: 10.1016/j.jsb.2017.02.003
Scheres, S. H. W. Amyloid structure determination in RELION-3.1. Acta Crystallogr. D. 76, 94–101 (2020).
doi: 10.1107/S2059798319016577
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
pubmed: 20383002
pmcid: 2852313
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
pubmed: 20124702
doi: 10.1107/S0907444909052925
pmcid: 2815670
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).
doi: 10.1107/S0907444909042073
pubmed: 20057044